The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
FREE Daily Email Newsletter
Lawsuit Alleges Merck Discriminates Against Women
May 9, 2013 11:48 am | by The Associated Press | News | CommentsA Merck & Co. sales representative is suing the drugmaker for at least $100 million, saying Merck doesn't give women equal opportunities for advancement and punishes employees for taking maternity leave. Kelli Smith, a Merck employee since 2004, says the company's sales plans create...
Nationwide Discrepancy in Hospital Costs
May 9, 2013 8:44 am | Videos | CommentsA new survey has found great discrepancies in the fees hospitals charge for certain procedures. The survey tracked the cost of 100 of the most common procedures and found huge prices differences not only across the country but between nearby facilities. The survey also found that the increased prices did not result in better care.
California Health Exchange Granted Secrecy
May 9, 2013 8:29 am | by MICHAEL R. BLOOD,Associated Press | News | CommentsA California law that created an agency to oversee national health care reforms granted it sweeping authority to conceal spending on the contractors that will perform most of its functions, creating a barrier from public disclosure that stands out nationwide.
Poor Sales of Qsymia Widens Vivus’ First Quarter Losses
May 9, 2013 8:25 am | by The Associated Press | News | CommentsShares of Vivus Inc. plunged in premarket trading Wednesday after the drug developer said it absorbed a $5.8 million charge to write off unsold inventory largely from its initial production of the weight-loss drug Qsymia. The Mountain View, Calif., company started marketing Qsymia last September, after it became the second long-term weight loss drug approved in the United States since 1999.
Orgenesis and ATMI Enter Into Process Development Agreement
May 9, 2013 8:21 am | News | CommentsOrgenesis Inc., a development-stage company with a novel therapeutic technology dedicated to converting a patient's own liver cells into functioning insulin-producing cells as a treatment for diabetes, announced today that its wholly owned subsidiary, Orgenesis Ltd., has entered into a process development agreement with ATMI, Inc., a global technology company and leader in single-use bioprocess solutions.
Study: Fish Oil Doesn't Help Prevent Heart Attacks
May 9, 2013 8:17 am | by MARILYNN MARCHIONE,AP Chief Medical Writer | News | CommentsEating fish is good for your heart but taking fish oil capsules does not help people at high risk of heart problems who are already taking medicines to prevent them, a large study in Italy found. The work makes clearer who does and does not benefit from taking supplements of omega-3 fatty acids, the good oils found in fish such as salmon, tuna and sardines.
Alexza Pharma Jumps on Adasuve Licensing Deal
May 9, 2013 8:09 am | News | CommentsShares of Alexza Pharmaceuticals Inc. jumped Wednesday after the company said Teva Pharmaceutical Industries Ltd., one of the world's largest drug companies, will market is agitation drug Adasuve in the U.S. The companies said Wednesday that Teva will be responsible for all U.S. commercial and clinical-related activities, including a required post-approval study.
Techulon Awarded $1.9M to Defeat “Superbugs”
May 9, 2013 8:06 am | News | CommentsTechulon, Inc. has been selected by the Defense Advanced Research Projects Agency (DARPA) for a Phase II contract to advance its therapeutic program for multi-drug resistant bacteria, or ‘superbugs.’ This award drives Techulon’s development of a nanotherapeutic agent that will give the Department of Defense and hospitals the ability to rapidly respond and treat patients with life-threatening multi-drug resistant infections.
IMS: US Medicine Spending Shows Rare Dip in 2012
May 9, 2013 8:00 am | by LINDA A. JOHNSON,AP Business Writer | News | CommentsSpending on prescription medicines in the U.S. fell for the first time in decades last year, slipping as cash-strapped consumers continued to cut back on use of health care services. Patients also benefited from a surge of new, inexpensive generic versions of widely used drugs for chronic conditions like high cholesterol, according to a new report.
Drugmakers, Health Groups Bring Poor Girls Vaccine
May 9, 2013 7:58 am | by LINDA A. JOHNSON,AP Business Writer | News | CommentsTwo multinational drugmakers are teaming up with top global health groups to protect millions of girls in the world's poorest countries from deadly cervical cancer. Starting with pilot programs in eight Asian and African nations, the ambitious project ultimately is intended to inoculate more than 30 million girls in more than 40 countries by 2020.
Dynamic Batching Station
May 8, 2013 3:31 pm | Product Releases | CommentsThe Dynamic Batching Station (DBS) is a skidded process module for batching dry powders into liquids. It can be fed dry powders or granular sugar from bulk trucks, bulk bags or other feed options. The fully automated process can operate as a “batch and pump” or “continuous steady state” and other operating modes.
Prostate Test Could Cut Need for Surgery
May 8, 2013 1:46 pm | by Wall Street Journal | Videos | CommentsA new genetic test can help distinguish between aggressive and low-risk forms of prostate cancer, which could enable many men to delay or forgo surgery to treat it. Over 220,000 men in the U.S. are diagnosed with prostate cancer anually.
Merck: FDA Reviewing its Ragweed Allergy Therapy
May 8, 2013 12:47 pm | by The Associated Press | News | CommentsWHITEHOUSE STATION, N.J. (AP) — Drugmaker Merck & Co. says the Food and Drug Administration is reviewing its second application to sell a new type of allergy treatment meant to gradually reduce allergic reactions over time, rather than just relieving sneezing, itching and other symptoms...
ProcessPro Launches Major Rebrand
May 8, 2013 12:14 pm | News | CommentsProcessPro, mid-market ERP software solution for process manufacturers, today announced a total brand review and with the unveiling of a new logo and tagline to support its evolution within the industry. The brand review also entails a website reveal scheduled tentatively for June 2013.
Cabinet U-Handles
May 8, 2013 10:15 am | Product Releases | CommentsThe EN 628.4 Cabinet U-Handles with Power Switching Function is available in metric sizes. These RoHS compliant U-handles feature a push button that allows two switching positions. The status is displayed by two LEDs, red or green. The red LED will be lit during normal function.
